Apex Biotechnology Corp (1733) — Free Cash Flow Generation Index
Apex Biotechnology Corp (1733) has a Free Cash Flow Generation Index of 0.43x as of September 2025. Free cash flow of NT$2.22 Million represents 0% of operating cash flow (NT$5.19 Million). Explore Apex Biotechnology Corp capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Apex Biotechnology Corp Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for Apex Biotechnology Corp across 23 annual periods. For the full cash flow conversion analysis, see how efficiently does Apex Biotechnology Corp generate cash.
Annual Free Cash Flow Generation for Apex Biotechnology Corp (2002–2024)
Year-by-year Free Cash Flow Generation Index for Apex Biotechnology Corp. Check Apex Biotechnology Corp (1733) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | NT$299.04 Million | NT$328.67 Million | NT$29.63 Million | ▲ +2.0% |
| 2023 | 0.89x | NT$205.41 Million | NT$230.39 Million | NT$24.98 Million | ▲ +274.7% |
| 2022 | -0.51x | NT$-13.58 Million | NT$26.62 Million | NT$40.20 Million | ▼ -159.7% |
| 2021 | 0.85x | NT$153.67 Million | NT$179.87 Million | NT$26.20 Million | ▲ +3.2% |
| 2020 | 0.83x | NT$232.28 Million | NT$280.60 Million | NT$48.32 Million | ▼ -5.7% |
| 2019 | 0.88x | NT$405.94 Million | NT$462.52 Million | NT$56.58 Million | ▲ +867.9% |
| 2018 | -0.11x | NT$-7.72 Million | NT$67.57 Million | NT$75.29 Million | ▼ -118.4% |
| 2017 | 0.62x | NT$44.07 Million | NT$70.83 Million | NT$26.76 Million | ▼ -28.6% |
| 2016 | 0.87x | NT$259.60 Million | NT$298.06 Million | NT$38.45 Million | ▼ -7.7% |
| 2015 | 0.94x | NT$445.49 Million | NT$472.15 Million | NT$26.66 Million | ▲ +24.9% |
| 2014 | 0.76x | NT$202.19 Million | NT$267.60 Million | NT$65.41 Million | ▲ +54.5% |
| 2013 | 0.49x | NT$237.08 Million | NT$484.77 Million | NT$247.69 Million | ▲ +162.5% |
| 2012 | 0.19x | NT$94.96 Million | NT$509.67 Million | NT$414.70 Million | ▼ -74.4% |
| 2011 | 0.73x | NT$198.82 Million | NT$273.45 Million | NT$74.63 Million | ▲ +11.2% |
| 2010 | 0.65x | NT$304.53 Million | NT$465.59 Million | NT$161.05 Million | ▼ -19.5% |
| 2009 | 0.81x | NT$317.95 Million | NT$391.29 Million | NT$73.34 Million | ▼ -43.3% |
| 2008 | 1.43x | NT$429.70 Million | NT$299.96 Million | NT$129.74 Million | ▲ +24.6% |
| 2007 | 1.15x | NT$419.34 Million | NT$364.62 Million | NT$54.71 Million | ▲ +3.1% |
| 2006 | 1.12x | NT$405.70 Million | NT$363.71 Million | NT$41.99 Million | ▼ -19.4% |
| 2005 | 1.38x | NT$293.44 Million | NT$212.14 Million | NT$81.30 Million | ▼ -35.6% |
| 2004 | 2.15x | NT$469.70 Million | NT$218.54 Million | NT$251.16 Million | ▲ +81.2% |
| 2003 | 1.19x | NT$358.46 Million | NT$302.25 Million | NT$56.21 Million | ▼ -33.0% |
| 2002 | 1.77x | NT$140.62 Million | NT$79.49 Million | NT$61.13 Million | — |